GRUSS & CO., LLC Holdings
GRUSS & CO., LLC is an investment fund managing more than 11.62M US dollars. The largest holdings include AbCellera Biologics, ProShares UltraShort 20+ Year Treasury and Blackstone Mortgage Trust. In Q3 2022 the fund bought assets of total value of 334K US dollars and sold assets of total value of 2.59M US dollars.
GRUSS & CO., LLC portfolio value:
$11.61M
portfolio value
GRUSS & CO., LLC quarter portfolio value change:
-23.84%
quarter
GRUSS & CO., LLC 1 year portfolio value change:
-55.21%
1 year
GRUSS & CO., LLC 3 years portfolio value change:
-5.38%
3 years
GRUSS & CO., LLC 5 years portfolio value change:
+20.33%
5 years
GRUSS & CO., LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 10013000 | 8551000 |
| Q2 2016 | 19295000 | 8546000 |
| Q3 2016 | 7867000 | 12357000 |
| Q4 2016 | 17687000 | 5292000 |
| Q1 2017 | 14925498 | 8726869 |
| Q2 2017 | 2167553 | 16147450 |
| Q3 2017 | 10365000 | 11327000 |
| Q4 2017 | 16746000 | 4682000 |
| Q1 2018 | 9543000 | 15259000 |
| Q2 2018 | 3365000 | 10626000 |
| Q3 2018 | 15753000 | 12763000 |
| Q4 2018 | 2816000 | 23016000 |
| Q1 2019 | 23209000 | 6675000 |
| Q2 2019 | 11548000 | 17116000 |
| Q3 2019 | 8423000 | 20483000 |
| Q4 2019 | 10191000 | 9982000 |
| Q1 2020 | -5460000 | 21833000 |
| Q2 2020 | 12602000 | 13909000 |
| Q3 2020 | 2323000 | 26358000 |
| Q4 2020 | 9408000 | 8920000 |
| Q1 2021 | 7901000 | 9913000 |
| Q2 2021 | 7990000 | 5267000 |
| Q3 2021 | 14363000 | 6034000 |
| Q4 2021 | 10985000 | 9736000 |
| Q1 2022 | 4140000 | 20052000 |
| Q2 2022 | 1037000 | 8682000 |
| Q3 2022 | 334000 | 2592000 |
GRUSS & CO., LLC 13F holdings
| Stock |
|---|
| Portfolio share: 26.27% Portfolio value: 3.05M Avg. open price: $9.75 Current price: $12.34 P/L: +26.56% Sold -15.18% shares Q3 2022 |
| Portfolio share: 15.74% Portfolio value: 1.82M Avg. open price: $17.96 Current price: $29.52 P/L: +64.33% Sold -4.17% shares Q3 2022 |
| Portfolio share: 14.59% Portfolio value: 1.69M Avg. open price: $18.12 Current price: $24.12 P/L: +33.12% Bought +1.55% shares Q2 2022 |
| Portfolio share: 13.05% Portfolio value: 1.51M Avg. open price: $10.12 Current price: $18 P/L: +77.95% Sold -20.51% shares Q3 2022 |
| Portfolio share: 6.65% Portfolio value: 773K Avg. open price: $162.8 Current price: $165.17 P/L: +1.46% Sold -50.00% shares Q2 2022 |
| Portfolio share: 5.11% Portfolio value: 594K Avg. open price: $33.85 Current price: $148.49 P/L: +338.62% Sold -1.38% shares Q2 2022 |
| Portfolio share: 4.40% Portfolio value: 511K Avg. open price: N/A Current price: $275.41 P/L: N/A N/A Q1 2021 |
| Portfolio share: 3.49% Portfolio value: 405K Avg. open price: $32.84 Current price: $45.84 P/L: +39.59% Bought +2.99% shares Q2 2022 |
| Portfolio share: 3.25% Portfolio value: 377K Avg. open price: $82.96 Current price: $251.65 P/L: +203.33% Sold -3.57% shares Q2 2022 |
| Portfolio share: 2.87% Portfolio value: 334K Avg. open price: N/A Current price: $1.18 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.59% Portfolio value: 301K Avg. open price: $36.82 Current price: $83.73 P/L: +127.40% Bought +9.09% shares Q2 2022 |
| Portfolio share: 1.02% Portfolio value: 119K Avg. open price: $16.42 Current price: $12.42 P/L: -24.36% Sold -50.00% shares Q3 2022 |
| Portfolio share: 0.65% Portfolio value: 75K Avg. open price: $62.64 Current price: $12.85 P/L: -79.49% Sold -35.71% shares Q3 2022 |
| Portfolio share: 0.32% Portfolio value: 37K Avg. open price: N/A Current price: $1 P/L: N/A N/A Q2 2021 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $240.45 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $123 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $383.75 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $15.38 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $986.45 Current price: $92.66 P/L: -90.61% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $873.67 Current price: $100.24 P/L: -88.53% Sold -100.00% shares Q3 2022 |
Showing TOP 20 GRUSS & CO.'s 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of GRUSS & CO., LLC?
The biggest position of the GRUSS & CO., LLC is AbCellera Biologics Inc. (ABCL) with 26.27% portfolio share worth of 3.05M US dollars.
Top 5 GRUSS & CO.'s holdings represent 76.3% of the portfolio:
- AbCellera Biologics Inc. (ABCL) – 26.27%
- ProShares UltraShort 20+ Year Treasury (TBT) – 15.74%
- Blackstone Mortgage Trust, Inc. (BXMT) – 14.59%
- Black Stone Minerals, L.P. (BSM) – 13.05%
- SPDR Gold Shares (GLD) – 6.65%
Who is the portfolio manager of GRUSS & CO., LLC?
The portfolio manager of the GRUSS & CO., LLC is .
What is the total asset value of the GRUSS & CO., LLC portfolio?
GRUSS & CO., LLC total asset value (portfolio value) is 11.62M US dollars.
Who is ?
is the portfolio manager of the GRUSS & CO., LLC.
What is (GRUSS & CO., LLC) fund performance?
GRUSS & CO.'s quarterly performance is -23.84%, annualy -55.21%. In the past 3 years, the value of 's portfolio has decreased by -5%. In the past 5 years, the value of the portfolio has increased by +20%.
What is the GRUSS & CO., LLC CIK?
GRUSS & CO.'s Central Index Key is 0001103738 .